Gene co-expression analysis identifies brain regions and cell types involved in migraine pathophysiology: a GWAS-based study using the Allen Human Brain Atlas
- 3.1k Downloads
Migraine is a common disabling neurovascular brain disorder typically characterised by attacks of severe headache and associated with autonomic and neurological symptoms. Migraine is caused by an interplay of genetic and environmental factors. Genome-wide association studies (GWAS) have identified over a dozen genetic loci associated with migraine. Here, we integrated migraine GWAS data with high-resolution spatial gene expression data of normal adult brains from the Allen Human Brain Atlas to identify specific brain regions and molecular pathways that are possibly involved in migraine pathophysiology. To this end, we used two complementary methods. In GWAS data from 23,285 migraine cases and 95,425 controls, we first studied modules of co-expressed genes that were calculated based on human brain expression data for enrichment of genes that showed association with migraine. Enrichment of a migraine GWAS signal was found for five modules that suggest involvement in migraine pathophysiology of: (i) neurotransmission, protein catabolism and mitochondria in the cortex; (ii) transcription regulation in the cortex and cerebellum; and (iii) oligodendrocytes and mitochondria in subcortical areas. Second, we used the high-confidence genes from the migraine GWAS as a basis to construct local migraine-related co-expression gene networks. Signatures of all brain regions and pathways that were prominent in the first method also surfaced in the second method, thus providing support that these brain regions and pathways are indeed involved in migraine pathophysiology.
KeywordsMigraine Migraine Patient Migraine With Aura GWAS Data Familial Hemiplegic Migraine
Migraine is a common neurovascular brain disorder characterised by attacks of severe, unilateral headache, often accompanied by nausea and phono- and photophobia (Headache Classification Committee 2013). Two main migraine types are distinguished based on the presence or absence of an aura, which consists of transient neurologic symptoms including visual and sensory disturbances that can precede attacks in up to one-third of patients. Migraine is a complex genetic disorder with an estimated heritability of approximately 50 % (Mulder et al. 2003) and thought to be caused by an interplay of multiple genetic variants, each with a small effect size, and environmental factors. Numerous candidate gene association studies have been performed for migraine, however, their value turned out rather low as none could be replicated in a large genome-wide marker dataset of thousands of migraine patients and controls (de Vries et al. 2015). Genome-wide association studies (GWAS) investigating the common forms of migraine have identified 13 disease susceptibility loci (Anttila et al. 2010, 2013; Chasman et al. 2011; Freilinger et al. 2012). These loci identified genes that are involved in glutamatergic neurotransmission (MTDH, LRP1, MEF2D), neuron and synapse development (MEF2D, ASTN2, PRDM16, FHL5, PHACTR1, TGFBR2 and MMP16), brain vasculature (PHACTR1, TGFBR2, C7orf10), extracellular matrix (MMP16, TSPAN2, AJAP1), and pain-sensing (TRPM8). These findings support knowledge that came from investigating disease mechanisms in monogenic migraine-related disorders including familial hemiplegic migraine (FHM), a monogenic subtype of migraine with aura (Ferrari et al. 2015; Tolner et al. 2015). Notably, transgenic knock-in (KI) mouse models that express human pathogenic FHM1 (van den Maagdenberg et al. 2004, 2010) or FHM2 (Leo et al. 2011) mutations revealed increased susceptibility for experimentally induced cortical spreading depression (CSD), the electrophysiological correlate of the migraine aura (Lauritzen 1994), which could be directly linked to increased cortical glutamatergic neurotransmission in FHM1 KI mice (Tottene et al. 2009). Other monogenic disorders in which migraine is prevalent are cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and retinal vasculopathy with cerebral leukodystrophy (RVCL) that indicate a role for dysfunction of the brain vasculature in migraine (Tolner et al. 2015). Migraine genes identified by GWAS are primarily identified based on their location near top hits, so true causality of (at least some of) them remains uncertain, which is not different from other disorders. Furthermore, current GWAS top hits explain only a small part of the disease heritability, and, therefore, genes identified in this way reflect only a fraction of the pathways conferring genetic disease risk. Hence, pathway analysis methods that harvest a larger portion of the GWAS data (i.e., not only loci with significant P values) may give more valuable insight into disease genetics, as has been tried for other diseases (Atias et al. 2013; Sun 2012).
Commonly used tools to explore disease-associated pathways in GWAS data make use of functional enrichments [MAGENTA Gene Set Enrichment Analysis (Segre et al. 2010)], protein interactions [DAPPLE (Rossin et al. 2011)] or text-mining [GRAIL (Raychaudhuri et al. 2009)], but did not successfully identify overrepresented molecular pathways involved in migraine (Anttila et al. 2013). One explanation why it may be difficult to confidently identify disease pathways from GWAS data is that loci often contain multiple genes, of which only (one or) a subset might influence the trait of interest. Moreover, each of these genes can be expressed in multiple cell types and may have different functions in each of them. We envisaged that gene expression data can be used to preselect genes for functional analysis based on their expression in disease-relevant tissues, thereby increasing the chance of identifying disease-relevant genes and pathways. In addition, gene co-expression analysis can be used to identify genes with similar expression patterns. Previous studies have shown that gene co-expression can infer a wide range of meaningful biological information, e.g., shared gene functions, biological pathways or cell type-specific expression (Kang et al. 2011; Hawrylycz et al. 2012; Grange et al. 2014).
Gene co-expression analysis has been applied successfully to identify disease mechanisms from GWAS or other genomics data for other disorders, including allergic rhinitis and autism spectrum disorder (Ben-David and Shifman 2012; Bunyavanich et al. 2014; Parikshak et al. 2013; Willsey et al. 2013). Admittedly, these studies benefited from having available gene expression data obtained under disease-specific conditions (Bunyavanich et al. 2014) or the use of causal genetic variants with large effect sizes (Ben-David and Shifman 2012; Parikshak et al. 2013; Willsey et al. 2013). For migraine, no gene expression data from disease-conditions are available. Few gene expression profiling studies have been carried out for migraine, i.e., in whole blood of episodic and chronic migraine patients (Hershey et al. 2004) and menstrual migraine patients (Hershey et al. 2012), in immortalised cell lines of migraine with aura patients (Nagata et al. 2009), and in brain material of transgenic KI FHM1 mice (de Vries et al. 2014), but no overlapping deregulated genes or pathways have been identified. Nor is there a large set of causal genes, except for three genes (CACNA1A, ATP1A2 and SCN1A) (De Fusco et al. 2003; Dichgans et al. 2005; Ophoff et al. 1996) that have been identified for FHM, that can guide gene identification efforts in the common forms of migraine. Therefore, we focused our analyses on gene expression data from the normal human brain.
Here we used two complementary methods to connect gene expression data from adult human brain, the most relevant tissue for migraine, with GWAS data to identify migraine-related pathways. To this end, spatially mapped gene expression data of the adult human brain, obtained from the Allen Human Brain Atlas (Hawrylycz et al. 2012), was used to calculate brain-specific co-expression levels between genes. We used GWAS data, available through the International Headache Genetics Consortium, of 23,285 migraine cases and 95,425 population-matched controls (Anttila et al. 2013) to calculate gene-based associations with migraine. This enabled the inclusion of below-threshold association signals that did not reach genome-wide significance (P value <5 × 10−8) due to lack of power (Gibson 2012; Mooney et al. 2014). For our first method, we grouped all genes into co-expression modules and studied the enrichment of genes with nominally significant gene-based associations with migraine in the different modules. For our second method, we constructed local co-expression networks around ‘high-confidence genes’ (i.e., those genes with gene-based P values that survived multiple testing correction) that we combined into a local migraine-related co-expression gene network. By studying the modules enriched for migraine-associated genes (method 1) and the local migraine-related co-expression gene networks (method 2), we identified multiple brain regions, cell types and pathways overlapping between the two methods that are possibly involved in migraine pathophysiology.
Spatial co-expression network of the adult human brain
Genes associated with migraine
We used summary statistics data from the GWAS meta-analysis for migraine (Anttila et al. 2013) performed by the International Headache Genetics Consortium to calculate gene-based P values for the association with migraine. The 2116 genes with nominal gene-based P values below 0.05 were considered to have a potential link to migraine and are therefore referred to as migraine ‘candidate genes’. The 14 genome-wide significant genes, with multiple testing corrected gene-based P values below 0.05, are referred to as ‘high-confidence genes’. The high-confidence genes contained 10 genes located at or near the genome-wide significant GWAS loci: ASTN2, C7orf10, FHL5, MEF2D, TRPM8, LRP1, STAT6, NAB2, PRDM16 and UFL1 (Anttila et al. 2013). LRP1, STAT6 and NAB2 at chromosome 12q13 share the same genome-wide significant SNP, and the top SNPs for FHL5 and UFL1 at chromosome 6q16 are in strong linkage disequilibrium (LD). The remaining high-confidence genes LEPROTL1, DCLRE1C, SUV39H2, and MBOAT4 are located near SNPs that did not reach the level of genome-wide significance in the migraine GWAS, and gain from a reduced multiple testing burden in our gene-based analysis compared to a SNP-based analysis. GWAS hits MTDH, PHACTR1, TGFBR2, MMP16, TSPAN2 and AJAP1 did not reach a multiple testing corrected gene-based P value below 0.05, possibly due to a larger distance between the GWAS locus and the gene, and were therefore not designated as high-confidence genes.
Migraine-associated loci converge into five co-expression modules
We performed an enrichment analysis of the 2116 migraine candidate genes in the 18 co-expression modules to identify the modules that have the strongest link with migraine. Five modules labelled A–E showed enrichment of candidate genes in a Fisher exact test (P < 0.05) (Fig. 1; Table S1). To verify that the identified enrichments were not the result of bias in the Fisher exact test introduced by LD between SNPs in the GWAS data and by SNPs assigned to multiple genes, we performed a second, LD-corrected Fisher exact test. These results confirm the association of modules A–E with migraine (Table S1).
Migraine-associated modules show enrichment of functions involved in neurotransmission, mitochondria, gene expression regulation and oligodendrocytes
Next, we performed a functional enrichment analysis of modules A–E to identify gene functions associated with migraine pathophysiology (Fig. 2; Tables S2–S5). We studied pathways from KEGG, Reactome and PANTHER, and gene ontology (GO) terms from PANTHER and the GO FAT database using the Functional Annotation Clustering tool in DAVID. GO term and pathway groups were considered significant when the Benjamini-corrected P value was below 0.05 (reflected in an EASE score of 1.3 or higher). Functions enriched in module A included energy metabolism, protein catabolism and synaptic functions (Table S2). Genes in module B showed enrichment of multiple functions, all involved in gene expression regulation (Table S3). Module C contains a large set of genes involved in purine nucleotide binding, and also showed enrichment for several brain developmental and synaptic functions (Table S4). Genes in module D showed highest enrichment of functions involving energy supply, apoptosis and myelination (Table S5). Module E did not show any significant functional enrichments. Most enriched functions are module-specific; of modules A–D only module C shares most of its enriched functions with other modules (A, L and P) (Figure S2).
Enrichment of oligodendrocytic and neuronal genes in migraine-associated modules
Expression patterns in the brain are co-determined by cell type composition (Grange et al. 2014; Hawrylycz et al. 2012). Consequently, we expected to find enrichment of cell type-specific genes in the co-expression modules (Fig. 1). Notably, modules A and C showed significant enrichment of genes specifically expressed in neurons (119 genes, P = 8.00 × 10−15; 40 genes P = 3.12 × 10−6, respectively), which is in line with the preferential expression in cerebral cortex of genes in these modules and the enrichment for synaptic functions. Module D is significantly enriched for oligodendrocyte-specific genes (103 genes, P = 1.37 × 10−55), and also showed enrichment for genes specifically expressed in microglia and endothelial cells. This finding seems well in line with the observed high expression in white matter of genes in this module and the enrichment of several functions related to myelination. Module E is enriched for neuron-specific genes (18 genes, P = 1.09 × 10−4). Module B did not show enrichment of cell type-specific genes.
Confirmation of the association of modules A–D with migraine using a local seed network
The most highly connected high-confidence gene is STAT6, which has strong co-expression with genes from module A (connections marked in blue in Fig. 3) and two genes from module C (connections marked in green), but is not part of either of these modules. Genes DCLRE1C and LRP1 lie in a sub-network containing genes from module B (connections marked in yellow). LEPROTL1 and UFL1 are directly connected to genes from module D (marked in red). SUV39H2 and TRPM8 have no strongly co-expressed genes in the Allen Human Brain Atlas and remain unconnected. MBOAT4 lies in a disconnected sub-network. The remaining 6 high-confidence genes are indirectly connected to the genes of modules A–D. The smallest module of interest, module E, has no genes in the local seed network.
Local seed network shows enrichment of functions and cell types similar to modules A–D
We performed a functional enrichment analysis in the local seed network, thereby focussing on each high-confidence gene and its co-expressing partners (Fig. 3; Table S6). Briefly, a local network for each high-confidence gene was constructed by connecting it to genes with which it has a spatial gene co-expression larger than 0.6. The network around STAT6, C7orf10 and MBOAT4 showed enrichment of functions involved in the synapse and signal transduction. The network around LEPROTL1 showed enrichment of mitochondrial genes. Functions involved in gene expression regulation were found in the networks around DCLRE1C, LRP1 and UFL1. Other enriched functions were “circadian rhythm” (NAB2 network), “apoptosis” (UFL1 network), and “protein catabolism” (LEPROTL1 network).
Finally, we investigated the enrichment of brain cell type-specific genes in the local seed network (Fig. 3; Table S7). The co-expression network around STAT6, that shares many genes with module A, is highly enriched for neuron-specific genes (P = 4.37 × 10−32), as is the network around NAB2 (P = 2.50 × 10−4). The sub-network connected to UFL1, overlapping with module D, contains many oligodendrocyte-specific genes (P = 1.26 × 10−8). The sub-networks connected to PRDM16 and to C7orf10 are enriched for astrocyte-specific genes (P = 3.82 × 10−7 and 4.34 × 10−10, respectively).
The lack of causal variants with large effect sizes for common migraine may explain, at least partly, the low enrichments of candidate genes in the co-expression modules. The conversion of the migraine GWAS data to the gene-based P values may have caused inaccuracies as we may have associated SNPs to genes just because they are nearby these genes, although they may not have a functional effect on them; and, similarly, we may not have associated SNPs to genes simply because we considered them too far away to be functionally involved. To reduce these limitations we chose a 15-kb boundary around the genes, as it was shown that most SNPs that affect gene expression are located within this boundary (Pickrell et al. 2010). However, currently, no methods are available to calculate gene-based P values that can fully surmount these limitations. To increase the reliability of our results, we used the largest migraine GWAS dataset currently available (Anttila et al. 2013). Furthermore, we used a second method to confirm the link between migraine and the brain regions and gene functions identified by building a migraine-related co-expression gene network around the high-confidence migraine genes. Although the enrichment of migraine-associated genes in the modules cannot proof that these brain regions, cells and pathways are dysfunctional in migraine patients, it can provide genetic evidence for processes already implicated in migraine, and may indicate new areas of interest for migraine research.
Two modules enriched for migraine-associated genes contained genes highly expressed in cortex that are largely involved in neurotransmission and that are highly enriched for neuron-specific genes (Modules A and C). Furthermore, module A contains many components of the glutamatergic system (GLS, GRIK3, GRIN2A and GRM7). The cell type enrichments in the modules were based on gene expression data from isolated mouse brain cells (Zhang et al. 2014). Similar data from mouse studies have been used previously for characterisation of human brain co-expression modules (Hawrylycz et al. 2015). These results confirm the link between cortical neurotransmission and migraine that had previously been identified in genetic studies in FHM (Ferrari et al. 2015). Several genes (MTDH, LRP1, MEF2D) identified by GWAS hits for common migraine could also be linked to glutamate signalling (Tolner et al. 2015), although these genes are not part of modules A or C.
The enrichment of genes involved in mitochondria in modules A and D form the first genetic link between mitochondrial function and common migraine. As neurotransmission requires a large amount of energy, it is not surprising that mitochondrial deficiencies have been implicated in a wide range of neurological disorders, including migraine (Sparaco et al. 2006). In migraine patients, magnetic resonance spectroscopy studies have consistently identified a depletion of brain high-energy phosphates, indicative of a disturbed energy metabolism (Reyngoudt et al. 2012). Impaired mitochondrial activity has also been found in muscle and platelets of migraine patients (Reyngoudt et al. 2012; Sangiorgi et al. 1994). Also the efficacy of riboflavin and coenzyme Q10, two enhancers of mitochondrial function, in migraine prophylaxis in two small clinical trials points towards a possible causal role for mitochondria in migraine (Sandor et al. 2005; Schoenen et al. 1998).
Module B shows high expression in cerebellum and medium expression in cortex, and is highly enriched for genes involved in aspects of gene expression regulation (i.e., transcription factors, chromatin remodellers, RNA processing). Migraine pathophysiology has already been associated with actions of a specific set of transcription factors, i.e., female hormone receptors and receptors for the stress hormone cortisol (MacGregor 2004; Sauro and Becker 2009). Although the stress hormone receptor gene NR3C1 is a member of module B, the other stress hormone receptor gene NR3C2 and the female hormone receptor genes ESR1, ESR2, RXFP1, RXFP2 and PGR are members of modules F, N, M, P, R and H, respectively. These transcription factors can thus not explain the association of module B with migraine. As to the high expression in cerebellum, there are several lines of evidence that indicate a role for the cerebellum in migraine. (Subclinical) cerebellar abnormalities have been recognised in migraine patients, including lack of fine coordination (Sandor et al. 2001) and vestibulocerebellar problems (Harno et al. 2003). Furthermore, studies using magnetic resonance imaging (MRI) identified cerebellar infarcts (Kruit et al. 2004) and microstructural cerebellar abnormalities (Granziera et al. 2013) in migraine patients. Cerebellar mechanisms causative of migraine are not known, but may possibly include signalling cascades that regulate gene expression as identified in module B.
Module D contains genes highly expressed in several subcortical brain regions and in the white matter and is enriched for gene functions involving myelin formation and genes specifically expressed in oligodendrocytes. Oligodendrocytes play key roles in the formation of axons and neuronal connections (Debanne et al. 2011), and can also actively communicate with neurons to regulate their activity (Butt et al. 2014; Fields 2008; Stys 2011). The genes from module D are expressed in multiple brain regions that are implicated in the processing of migraine pain signalling: the trigeminovascular pathway (Noseda and Burstein 2013). This pathway transmits nociceptive signals from meninges to thalamus and higher brain areas via several brainstem nuclei, including the trigeminal nucleus caudalis (TNC), (Fig. 4). A recent study identified disrupted myelin sheets in the trigeminal nerve of migraine patients (Guyuron et al. 2014), providing first evidence for disturbed oligodendrocyte functioning in the trigeminovascular pathway. Furthermore, a high-field MRI study identified thalamic microstructural abnormalities in migraine patients that could indicate an increase of myelin (Granziera et al. 2014).
In summary, we performed a gene-based analysis of the migraine GWAS data, using detailed spatial gene expression data to define gene modules with similar expression patterns in the normal human brain. Our results showed enrichment of migraine-associated genes in modules involved in cortical neurotransmission, mitochondrial and oligodendrocyte function that provide further evidence that these mechanisms play a causal role in migraine and deserve to be investigated in more detail by (functional) studies in patients and experimental animal models.
Materials and methods
Summary statistics of migraine GWAS data from 23,285 cases and 95,425 controls from the meta-analysis (Anttila et al. 2013) available through the International Genetics Headache Consortium were used for this study. The quality control of the genotype data was described previously (Anttila et al. 2013). Autosomal SNPs were imputed against the HapMap CEU population (release 21–24 depending on the cohort). To convert the genomic coordinates of the SNPs from human reference genome build 36 to build 37, we used CrossMap (http://crossmap.sourceforge.net/) (Zhao et al. 2014). A total of 1,853,579 SNPs with high quality GWAS data and converted to build 37 were used in the calculation of gene-based P values.
Gene-based P values
Gene-based P values were calculated from GWAS data using the gene-based test GATES (Li et al. 2011) implemented in the whole-genome analysis platform Fast ASsociation Test (FAST) (Chanda et al. 2013). GATES is a Simes test extension that integrates SNP P values into a gene-based test statistic, based on SNP positions and LD information [1000 Genomes data (Phase 1)] by taking the top SNP per gene and correcting its P value for the effective number of independent tests. Gene location information based on the GRCh37.p13 build reference sequence was obtained from Biomart (version 75: Feb 2014 archive site). A flanking region of 15 kb up- and downstream of the gene was used to include SNPs located in regulatory regions. The size of the flanking region was based on the identification that most SNPs that influence the expression of a gene are located within 15 kb of the gene (Pickrell et al. 2010). Genes with a gene-based P < 0.05 were considered migraine ‘candidate genes’; genes with a Bonferroni corrected P < 0.05 were considered ‘high-confidence genes’.
Spatial gene expression
Spatial gene expression data from six healthy adult human brains was obtained from the Allen Human Brain Atlas (http://human.brain-map.org/) (Hawrylycz et al. 2012). For each brain, RNA had been extracted from 363 to 946 different brain samples and measured on custom Agilent microarrays containing the 4 × 44 K Agilent Whole Human Genome probes as well as an additional 16,000 custom probes. The expression data was matched to the GATES output based on Biomart associations of 4 × 44 K Whole Genome microarray probe IDs with genes. If a probe was matched to multiple genes, it was excluded from the analysis. If multiple probe IDs were associated with the same gene, average expression levels were calculated for that gene. The spatial expression of a gene for a particular brain is thus described by the expression levels of that gene across all samples in that brain. Since the number of brain samples differs per brain, the spatial gene expression vector of a gene differs in length between brains.
Spatial gene co-expression and hierarchical clustering
Spatial co-expressions between genes were first calculated for each brain separately. For this, robust bi-weight mid-correlations were calculated across all brain samples for each of the six donors separately (Langfelder and Horvath 2012). Subsequently, these correlations were averaged across the donors to obtain co-expression values that only reflect spatial expression patterns and ignore between-brain differences. We then performed hierarchical clustering to obtain modules of spatially co-expressed genes. The linkage and distance measures, and the threshold at which the tree is cut, were chosen to maximise the enrichment of migraine candidate genes (see Supplementary Materials and methods for different combinations of linkage and distance measures). We chose for this independent evaluation over traditional cluster evaluation measures [like WGCNA (Zhang and Horvath 2005)] as we are interested in finding modules (clusters) that are related to migraine genes. Eventually, clustering was done with complete linkage, with one minus the bi-weight mid-correlation as a distance measure, and the tree was cut into 18 clusters.
Enrichment of candidate genes in the modules
Enrichment of migraine-associated genes within a module was determined using a Fisher exact test that calculated whether the number of migraine candidate genes in a module is higher than expected based on the total number of genes and migraine candidate genes. Neighbouring genes on the genome might have similar expression patterns due to local regulatory DNA elements, as well as similar gene-based P values due to LD between their top SNPs or overlapping flanking regions. Therefore, we performed a second LD-corrected Fisher exact test in which we included only the number of independent genes in the calculation. As a measure for the number of independent genes in a gene set, we took the top SNP of each gene and used the Genetic type I Error Calculator (GEC) (Li et al. 2012) to calculate the effective number of independent SNPs based on LD information from the HapMap project release 23. In this way, the LD-corrected Fisher exact test had as input the corrected estimates for the number of independent genes with gene-based P values below and above 0.05, both in the cluster of interest and in the full set of genes. See Supplementary Materials and methods for additional information on the enrichment analysis.
Gene ontology (GO) term and pathway enrichment analysis in the modules was performed with DAVID (version 6.7; http://david.abcc.ncifcrf.gov/). We used the Functional Annotation Clustering tool in DAVID to group significant GO terms and pathways based on co-associated genes to remove redundant terms (Huang et al. 2007). Pathway information from KEGG, Reactome and PANTHER, and GO term information (biological processes, molecular functions and cellular components) from PANTHER, and the FAT subsets of GO terms was used. GO term and pathway groups were considered significant when the EASE score was larger than 1.3 (corresponding to a geometric mean Benjamini-corrected P value of the clustered GO terms and pathways below 0.05). Significant groups were named after the most significant term in the group. Comparison of GO term and pathway enrichments between modules was performed in ToppCluster, a multiple gene list feature enrichment analyser (Kaimal et al. 2010). In ToppCluster, we performed GO term (biological processes, molecular functions and cellular components) and pathway enrichment analyses for all modules, which were considered significant when Bonferroni-corrected P values were below 0.05. Functional enrichments and overlap in enrichments between modules were visualised in Cytoscape (version 3.2.1).
Cell type enrichment
For enrichment analysis of cell type-specific genes we made use of cell type-specific genes identified in gene expression data from isolated mouse brain cells (Zhang et al. 2014). We selected the gene expression data from neurons, astrocytes, myelinating oligodendrocytes, microglia, and endothelial cells. Genes were considered cell type-specific if they had more than tenfold higher gene expression [reads per kb per million (RPKM)] levels compared to the mean expression in the other cell types. We obtained 818 neuron-, 380 astrocyte-, 198 oligodendrocyte-, 692 microglia-, and 546 endothelial-specific genes for which human orthologs were present. Enrichment was determined with Fisher exact tests.
Local modules from seed genes
Local co-expression networks were built from high-confidence genes by adding genes to the network whose co-expression exceeds a threshold [similar to Willsey et al. (2013)]. Genes were only selected if they had co-expression values higher than 0.6 with a high-confidence gene. The threshold was chosen to: (1) maintain only reasonably strong links between genes, especially given the fact that we use robust bi-weight mid-correlations; and (2) have linking genes for most of the seed genes (see Supplementary Materials and methods for information on how the threshold value was selected). Co-expressions were measured as bi-weight mid-correlations, the same co-expression values which were used to determine the genome-wide co-expression modules, and local modules were defined as all genes connected to a single high-confidence gene. If a gene is connected to two high-confidence genes, it is part of the modules of both genes.
This research was supported by the Dutch Technology Foundation STW, as part of the STW Project 12721: “Genes in Space” under the IMAGENE perspective program; the Spinoza (2009) Grant to M.D.F.; European Union Seventh Framework Programme Projects EUROHEADPAIN Project [Grant Number 602633] & Human Brain Project [Grant Number 604102]; the Center for Medical Systems Biology (CMSB) established in the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO) [Project Nr. 050‐060‐409]; and the Orion Farmos Research Foundation (to V.A.). The authors gratefully acknowledge the Allen Institute for Brain Science.
International Headache Genetics Consortium: Verneri Anttila, Bendik S. Winsvold, Tobias Kurth, M. Arfan Ikram, Tobias Freilinger, Jaakko Kaprio, Dorret I. Boomsma, Cornelia M. van Duijn, Marjo-Riitta R. Järvelin, John-Anker Zwart, Lydia Quaye, David P. Strachan, Christian Kubisch, Martin Dichgans, George Davey Smith, Kari Stefansson, Aarno Palotie
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Anttila V, Stefansson H, Kallela M, Todt U, Terwindt GM, Calafato MS, Nyholt DR, Dimas AS, Freilinger T, Muller-Myhsok B, Artto V, Inouye M, Alakurtti K, Kaunisto MA, Hamalainen E, de Vries B, Stam AH, Weller CM, Heinze A, Heinze-Kuhn K, Goebel I, Borck G, Gobel H, Steinberg S, Wolf C, Bjornsson A, Gudmundsson G, Kirchmann M, Hauge A, Werge T, Schoenen J, Eriksson JG, Hagen K, Stovner L, Wichmann HE, Meitinger T, Alexander M, Moebus S, Schreiber S, Aulchenko YS, Breteler MM, Uitterlinden AG, Hofman A, van Duijn CM, Tikka-Kleemola P, Vepsalainen S, Lucae S, Tozzi F, Muglia P, Barrett J, Kaprio J, Farkkila M, Peltonen L, Stefansson K, Zwart JA, Ferrari MD, Olesen J, Daly M, Wessman M, van den Maagdenberg AM, Dichgans M, Kubisch C, Dermitzakis ET, Frants RR, Palotie A, International Headache Genetics C (2010) Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet 42:869–873CrossRefPubMedPubMedCentralGoogle Scholar
- Anttila V, Winsvold BS, Gormley P, Kurth T, Bettella F, McMahon G, Kallela M, Malik R, de Vries B, Terwindt G, Medland SE, Todt U, McArdle WL, Quaye L, Koiranen M, Ikram MA, Lehtimaki T, Stam AH, Ligthart L, Wedenoja J, Dunham I, Neale BM, Palta P, Hamalainen E, Schurks M, Rose LM, Buring JE, Ridker PM, Steinberg S, Stefansson H, Jakobsson F, Lawlor DA, Evans DM, Ring SM, Farkkila M, Artto V, Kaunisto MA, Freilinger T, Schoenen J, Frants RR, Pelzer N, Weller CM, Zielman R, Heath AC, Madden PA, Montgomery GW, Martin NG, Borck G, Gobel H, Heinze A, Heinze-Kuhn K, Williams FM, Hartikainen AL, Pouta A, van den Ende J, Uitterlinden AG, Hofman A, Amin N, Hottenga JJ, Vink JM, Heikkila K, Alexander M, Muller-Myhsok B, Schreiber S, Meitinger T, Wichmann HE, Aromaa A, Eriksson JG, Traynor BJ, Trabzuni D, Rossin E, Lage K, Jacobs SB, Gibbs JR, Birney E, Kaprio J, Penninx BW, Boomsma DI, van Duijn C, Raitakari O, Jarvelin MR, Zwart JA, Cherkas L, Strachan DP, Kubisch C, Ferrari MD, van den Maagdenberg AM, Dichgans M, Wessman M, Smith GD, Stefansson K, Daly MJ, Nyholt DR, Chasman DI, Palotie A, North American Brain Expression C, Consortium UKBE, International Headache Genetics C (2013) Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet 45:912–917CrossRefPubMedPubMedCentralGoogle Scholar
- Bunyavanich S, Schadt EE, Himes BE, Lasky-Su J, Qiu W, Lazarus R, Ziniti JP, Cohain A, Linderman M, Torgerson DG, Eng CS, Pino-Yanes M, Padhukasahasram B, Yang JJ, Mathias RA, Beaty TH, Li X, Graves P, Romieu I, Navarro Bdel R, Salam MT, Vora H, Nicolae DL, Ober C, Martinez FD, Bleecker ER, Meyers DA, Gauderman WJ, Gilliland F, Burchard EG, Barnes KC, Williams LK, London SJ, Zhang B, Raby BA, Weiss ST (2014) Integrated genome-wide association, coexpression network, and expression single nucleotide polymorphism analysis identifies novel pathway in allergic rhinitis. BMC Med Genomics 7:48CrossRefPubMedPubMedCentralGoogle Scholar
- Chasman DI, Schurks M, Anttila V, de Vries B, Schminke U, Launer LJ, Terwindt GM, van den Maagdenberg AM, Fendrich K, Volzke H, Ernst F, Griffiths LR, Buring JE, Kallela M, Freilinger T, Kubisch C, Ridker PM, Palotie A, Ferrari MD, Hoffmann W, Zee RY, Kurth T (2011) Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet 43:695–698CrossRefPubMedPubMedCentralGoogle Scholar
- de Vries B, Anttila V, Freilinger T, Wessman M, Kaunisto MA, Kallela M, Artto V, Vijfhuizen LS, Göbel H, Dichgans M, Kubisch C, Ferrari MD, Palotie A, Terwindt GM, van den Maagdenberg AM; on behalf of the International Headache Genetics Consortium (2015) Systematic re-evaluation of genes from candidate gene association studies in migraine using a large genome-wide association data set. Cephalalgia (in press). pii: 0333102414566820Google Scholar
- Freilinger T, Anttila V, de Vries B, Malik R, Kallela M, Terwindt GM, Pozo-Rosich P, Winsvold B, Nyholt DR, van Oosterhout WP, Artto V, Todt U, Hamalainen E, Fernandez-Morales J, Louter MA, Kaunisto MA, Schoenen J, Raitakari O, Lehtimaki T, Vila-Pueyo M, Gobel H, Wichmann E, Sintas C, Uitterlinden AG, Hofman A, Rivadeneira F, Heinze A, Tronvik E, van Duijn CM, Kaprio J, Cormand B, Wessman M, Frants RR, Meitinger T, Muller-Myhsok B, Zwart JA, Farkkila M, Macaya A, Ferrari MD, Kubisch C, Palotie A, Dichgans M, van den Maagdenberg AM, International Headache Genetics Consortium (2012) Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 44:777–782CrossRefPubMedPubMedCentralGoogle Scholar
- Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, van de Lagemaat LN, Smith KA, Ebbert A, Riley ZL, Abajian C, Beckmann CF, Bernard A, Bertagnolli D, Boe AF, Cartagena PM, Chakravarty MM, Chapin M, Chong J, Dalley RA, Daly BD, Dang C, Datta S, Dee N, Dolbeare TA, Faber V, Feng D, Fowler DR, Goldy J, Gregor BW, Haradon Z, Haynor DR, Hohmann JG, Horvath S, Howard RE, Jeromin A, Jochim JM, Kinnunen M, Lau C, Lazarz ET, Lee C, Lemon TA, Li L, Li Y, Morris JA, Overly CC, Parker PD, Parry SE, Reding M, Royall JJ, Schulkin J, Sequeira PA, Slaughterbeck CR, Smith SC, Sodt AJ, Sunkin SM, Swanson BE, Vawter MP, Williams D, Wohnoutka P, Zielke HR, Geschwind DH, Hof PR, Smith SM, Koch C, Grant SG, Jones AR (2012) An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489:391–399CrossRefPubMedPubMedCentralGoogle Scholar
- Hawrylycz M, Miller JA, Menon V, Feng D, Dolbeare T, Guillozet-Bongaarts AL, Jegga AG, Aronow BJ, Lee CK, Bernard A, Glasser MF, Dierker DL, Menche J, Szafer A, Collman F, Grange P, Berman KA, Mihalas S, Yao Z, Stewart L, Barabási AL, Schulkin J, Phillips J, Ng L, Dang C, Haynor DR, Jones A, Van Essen DC, Koch C, Lein E (2015) Canonical genetic signatures of the adult human brain. Nat Neurosci 18:1832–1844CrossRefPubMedGoogle Scholar
- Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC, Lempicki RA (2007) The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8:R183CrossRefPubMedPubMedCentralGoogle Scholar
- Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, Sousa AM, Pletikos M, Meyer KA, Sedmak G, Guennel T, Shin Y, Johnson MB, Krsnik Z, Mayer S, Fertuzinhos S, Umlauf S, Lisgo SN, Vortmeyer A, Weinberger DR, Mane S, Hyde TM, Huttner A, Reimers M, Kleinman JE, Sestan N (2011) Spatio-temporal transcriptome of the human brain. Nature 478:483–489CrossRefPubMedPubMedCentralGoogle Scholar
- Langfelder P, Horvath S (2012) Fast R functions for robust correlations and hierarchical clustering. J Stat Softw 46(i11)Google Scholar
- Noseda R, Burstein R (2013) Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain 154(Suppl):1Google Scholar
- Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87:543–552CrossRefPubMedGoogle Scholar
- Raychaudhuri S, Plenge RM, Rossin EJ, Ng AC, International Schizophrenia C, Purcell SM, Sklar P, Scolnick EM, Xavier RJ, Altshuler D, Daly MJ (2009) Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet 5:e1000534CrossRefPubMedPubMedCentralGoogle Scholar
- Rossin EJ, Lage K, Raychaudhuri S, Xavier RJ, Tatar D, Benita Y, International Inflammatory Bowel Disease Genetics C, Cotsapas C, Daly MJ (2011) Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet 7:e1001273CrossRefPubMedPubMedCentralGoogle Scholar
- Tottene A, Conti R, Fabbro A, Vecchia D, Shapovalova M, Santello M, van den Maagdenberg AMJM, Ferrari MD, Pietrobon D (2009) Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice. Neuron 61:762–773CrossRefPubMedGoogle Scholar
- van den Maagdenberg AMJM, Pietrobon D, Pizzorusso T, Kaja S, Broos LA, Cesetti T, van de Ven RC, Tottene A, van der Kaa J, Plomp JJ, Frants RR, Ferrari MD (2004) A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41:701–710CrossRefPubMedGoogle Scholar
- van den Maagdenberg AMJM, Pizzorusso T, Kaja S, Terpolilli N, Shapovalova M, Hoebeek FE, Barrett CF, Gherardini L, van de Ven RC, Todorov B, Broos LA, Tottene A, Gao Z, Fodor M, De Zeeuw CI, Frants RR, Plesnila N, Plomp JJ, Pietrobon D, Ferrari MD (2010) High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice. Ann Neurol 67:85–98CrossRefPubMedGoogle Scholar
- Willsey AJ, Sanders SJ, Li M, Dong S, Tebbenkamp AT, Muhle RA, Reilly SK, Lin L, Fertuzinhos S, Miller JA, Murtha MT, Bichsel C, Niu W, Cotney J, Ercan-Sencicek AG, Gockley J, Gupta AR, Han W, He X, Hoffman EJ, Klei L, Lei J, Liu W, Liu L, Lu C, Xu X, Zhu Y, Mane SM, Lein ES, Wei L, Noonan JP, Roeder K, Devlin B, Sestan N, State MW (2013) Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 155:997–1007CrossRefPubMedPubMedCentralGoogle Scholar
- Zhang B, Horvath S (2005) A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 4: Article17Google Scholar
- Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O’Keeffe S, Phatnani HP, Guarnieri P, Caneda C, Ruderisch N, Deng S, Liddelow SA, Zhang C, Daneman R, Maniatis T, Barres BA, Wu JQ (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34:11929–11947CrossRefPubMedPubMedCentralGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.